As noted above, IVF PGT-M of SMA can rely solely on multi-marker haplotype analysis when DNA from an affected offspring is available for a priori assignment of the parental normal/SMN1-positive and mutant/SMN1-deleted haplotypes. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.